DongKookPharmaceuticalCo.,Ltd. Logo

DongKookPharmaceuticalCo.,Ltd.

Develops, manufactures, and distributes pharmaceuticals and healthcare products globally.

086450 | KO

Overview

Corporate Details

ISIN(s):
KR7086450004
LEI:
Country:
South Korea
Address:
서울특별시 강남구 영동대로 715 동국제약 청담빌딩, 강남구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1968, Dongkook Pharmaceutical Co., Ltd. is a company engaged in the research, development, manufacture, and distribution of pharmaceuticals, medical devices, and healthcare products. With a core philosophy centered on improving human life, the company focuses on human-oriented R&D and operates its own Active Pharmaceutical Ingredient (API) synthesis facilities. Its diverse portfolio includes prescription and non-prescription drugs, generic medications, and specialized therapeutic products such as anesthetics, contrast media, and anti-cancer agents. The company also produces well-known consumer brands like Madecassol and Oramedy, serving both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 5.9 MB
2025-08-12 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB
2025-07-10 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 413.5 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 3.0 MB
2025-03-21 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.0 KB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 24.6 KB
2025-03-13 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 666.2 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.1 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 187.3 KB
2025-02-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.9 KB
2025-02-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 11.2 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-12-13 00:00
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.7 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 1.6 MB
2024-10-15 00:00
M&A Activity
타법인주식및출자증권취득결정
Korean 33.7 KB

Automate Your Workflow. Get a real-time feed of all DongKookPharmaceuticalCo.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DongKookPharmaceuticalCo.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DongKookPharmaceuticalCo.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany
FYB
Fortress Biotech, Inc. Logo
Acquires, develops, and commercializes drugs for oncology, gene therapy, and rare diseases.
United States of America
FBIO
FRACTYL HEALTH, INC. Logo
Developing gut-targeted endoscopic and gene therapies for obesity and type 2 diabetes.
United States of America
GUTS
Friulchem Logo
CDMO for animal health, providing vet pharma & supplement solutions for pets and livestock.
Italy
FCM
Fuji Pharma Co.,Ltd. Logo
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
Japan
4554
Fulcrum Therapeutics, Inc. Logo
Develops gene-modulating small molecule drugs for rare, genetically defined diseases.
United States of America
FULC
Fuso Pharmaceutical Industries,Ltd. Logo
Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.
Japan
4538
FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.
South Korea
220100
Future Medicine  Co., Ltd. Logo
Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.
South Korea
341170
Develops long-acting injectable therapies for chronic diseases and cancer.
South Korea
456160

Talk to a Data Expert

Have a question? We'll get back to you promptly.